Extracellular matrix complexity in Q1 biomarker studies: a novel assay Q2 detecting total serum tenascin-C reveals different distribution to isoform-specific assays
MIDWOOD KIM., (2023), Frontiers in immunology
Chemokine Binding to Tenascin-C Influences Chemokine-Induced Immune Cell Migration.
Domaingo A. et al, (2023), Int j mol sci, 24
Investigating Chemokine-Matrix Networks in Breast Cancer: Tenascin-C Sets the Tone for CCL2.
Gschwandtner M. et al, (2023), Int j mol sci, 24
Tenascin-C is a driver of inflammation in the DSS model of colitis
MIDWOOD KIM., (2022), Matrix biology plus
FAS2FURIOUS: Moderate-throughput secreted expression of difficult recombinant proteins in Drosophila S2 cells
MIDWOOD KIM. et al, (2022), Frontiers in bioengineering and biotechnology, section synthetic biology
Tenascin-C in fibrosis in multiple organs: translational implications
MIDWOOD KIM. et al, (2022), Seminars in cell and developmental biology
Tenascins: key players in tissue homeostasis and defence
Midwood K., (2022), Frontiers in immunology
Editorial: Tenascins - Key Players in Tissue Homeostasis and Defense
MIDWOOD KIM., (2022), Frontiers in immunology
Decoding Inflammatory Signals from the Extracellular Matrix for the Development of New Immunotherapies
Midwood K., (2021), Faseb journal, 35
Tenascin-C immobilizes infiltrating T lymphocytes through CXCL12 promoting breast cancer progression
MIDWOOD KIM., (2021), Embo molecular medicine
Author Correction: Location, location, location: how the tissue microenvironment affects inflammation in RA.
Buckley CD. et al, (2021), Nat rev rheumatol, 17
Location, location, location: how the tissue microenvironment affects inflammation in RA.
Buckley CD. et al, (2021), Nat rev rheumatol, 17, 195 - 212
Location, location, location: understanding how the local tissue microenvironment drives inflammation in arthritis
BUCKLEY C. et al, (2020), Nature reviews rheumatology
T and B Cell Responses to Common Tenascin-C Peptides in RA
Song J. et al, (2020), Arthritis & rheumatology, 72
Alternative splicing controls cell lineage-specific responses to endogenous innate immune triggers within the extracellular matrix.
Giblin SP. et al, (2020), Matrix biol
Response to: 'Potential roles for tenascin in (very) early diagnosis and treatment of rheumatoid arthritis' by Cutolo et al.
Aungier S. et al, (2020), Ann rheum dis, 79
Matrix-Targeting Immunotherapy Controls Tumor Growth and Spread by Switching Macrophage Phenotype.
Deligne C. et al, (2020), Cancer immunol res, 8, 368 - 382
Identification of TNFR2 and IL-33 as therapeutic targets in localized fibrosis.
Izadi D. et al, (2019), Sci adv, 5
Tenascin-C: a driver of inflammatory bowel disease?
Ozanne J. et al, (2019), International journal of experimental pathology, 100, A29 - A30